Cargando…

Environmental Surveillance of Polioviruses in Armenia, Colombia before Trivalent Oral Polio Vaccine Cessation

Although acute flaccid paralysis (AFP) surveillance is the “gold standard” for detecting cases of polio, environmental surveillance can provide supplementary information in the absence of paralytic poliomyelitis cases. This study aimed to detect the introduction and/or circulation of wild poliovirus...

Descripción completa

Detalles Bibliográficos
Autores principales:	González, María Mercedes, Fonseca, Magile C., Rodríguez, Carlos Andrés, Giraldo, Alejandra María, Vila, José Joaquín, Castaño, Jhon Carlos, Padilla, Leonardo, Sarmiento, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783851/ https://www.ncbi.nlm.nih.gov/pubmed/31450757 http://dx.doi.org/10.3390/v11090775

Ejemplares similares

Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
por: Zhao, Ting, et al.
Publicado: (2021)

Giardiasis in children living in post-earthquake camps from Armenia (Colombia)
por: Lora-Suarez, Fabiana, et al.
Publicado: (2002)

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region
por: Tevi-Benissan, Carol, et al.
Publicado: (2017)

Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study
por: Taniuchi, Mami, et al.
Publicado: (2017)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
por: Hassan, Joanne, et al.
Publicado: (2017)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

Managing the Planned Cessation of a Global Supply Market: Lessons Learned From the Global Cessation of the Trivalent Oral Poliovirus Vaccine Market
por: Rubin, Jennifer, et al.
Publicado: (2017)

Resource Needs for the Trivalent Oral Polio to Bivalent Oral Polio Vaccine Switch in Indonesia
por: Holmes, Marionette, et al.
Publicado: (2017)

Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan
por: Voorman, Arie, et al.
Publicado: (2020)

Circulating Vaccine Derived Poliovirus and the polio eradication endgame
por: Davis, Robert, et al.
Publicado: (2012)

Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame
por: Thompson, Kimberly M., et al.
Publicado: (2020)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine — Worldwide, 2013–2016
Publicado: (2015)

Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame
por: Pons-Salort, Margarita, et al.
Publicado: (2016)

Persistence of protective anti-poliovirus antibody levels in 4-year-old children previously primed with Picovax®, a trivalent, aluminium-adjuvanted reduced dose inactivated polio vaccine
por: Sáez-Llorens, Xavier, et al.
Publicado: (2022)

Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine
por: Blake, Isobel M., et al.
Publicado: (2018)

Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2018)

In-Vitro Inactivation of Sabin-Polioviruses for Development of Safe and Effective Polio Vaccine
por: Abd-Elghaffar, Asmaa A., et al.
Publicado: (2020)

The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region
por: Bahl, Sunil, et al.
Publicado: (2017)

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame
por: Parker, Edward PK, et al.
Publicado: (2015)

Assessing the Risks for Poliovirus Outbreaks in Polio-Free Countries — Africa, 2012–2013
Publicado: (2013)

Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication
por: Aghamohammadi, Asghar, et al.
Publicado: (2017)

Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
por: Ming, Long Chiau, et al.
Publicado: (2020)

The resurgence of wild poliovirus in Pakistan and Afghanistan: A new setback for polio eradication
por: Rana, Muhammad Suleman, et al.
Publicado: (2022)

Smoking behavior, attitudes, and cessation counseling among healthcare professionals in Armenia
por: Movsisyan, Narine K, et al.
Publicado: (2012)

Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2018)

La sorveglianza ambientale per poliovirus e non-polio enterovirus a Parma nell’ambito del “Global Polio Eradication Program” (GPEI)
por: Zoni, Roberta, et al.
Publicado: (2019)

Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
por: Galal, Nermeen M., et al.
Publicado: (2018)

Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2018)

Experience With Inactivated Polio Vaccine Introduction and the “Switch” From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization’s Western Pacific Region
por: Gurung, Santosh, et al.
Publicado: (2017)

Challenges associated with the recent outbreaks of wild-type Poliovirus in previously polio-free countries
por: Arya, Subhash C., et al.
Publicado: (2013)

Interim CDC Guidance for Polio Vaccination for Travel to and from Countries Affected by Wild Poliovirus
por: Wallace, Gregory S., et al.
Publicado: (2014)

Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication
por: Thompson, Kimberly M., et al.
Publicado: (2020)

Armenia /
por: Alem, Jean Pierre [Callot]
Publicado: (1963)

Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative
por: Dunn, Glynis, et al.
Publicado: (2015)

Environmental surveillance of poliovirus and non-polio enterovirus in urban sewage in Dakar, Senegal (2007-2013)
por: Ndiaye, Abdou Kader, et al.
Publicado: (2014)

Eliminating all circulating vaccine-derived poliovirus: a prerequisite to declaring global polio eradication
por: Durrheim, David N
Publicado: (2022)

Polio eradication vaccine investment: how do we ensure polio vaccines are available to keep the world polio-free after transmission of wild poliovirus (wPV) has been interrupted?
por: Batson, Amie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9vj1rnqthh0har5otvoc6jopip